Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Davies, Nicholas G., Abbott, Sam, Barnard, Rosanna C., Jarvis, Christopher I., Kucharski, Adam J., Munday, James D., Pearson, Carl A. B., Russell, Timothy W. +17 more·2020·Science

DOI 10.1101/2020.12.24.20248822

Cited by (1,005)

Items 101–200 of 1,005

Early detection and surveillance of SARS-CoV-2 genomic variants in wastewater using COJAC
Katharina Jahn, David Dreifuss, Ivan Topolsky, Anina Kull, Pravin Ganesanandamoorthy, Xavier Fernández-Cassi, Carola Bänziger, Alexander J. Devaux, Elyse N. Stachler, Lea Caduff et al. · 2022 · Nature Microbiology
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
Chantal B. F. Vogels, Mallery I. Breban, Isabel M. Ott, Tara Alpert, Mary E. Petrone, Anne E. Watkins, Chaney C. Kalinich, Rebecca Earnest, Jessica E. Rothman, Jaqueline Góes de Jesus et al. · 2021 · PLoS Biology
Emerging SARS-CoV-2 variants of concern and potential intervention approaches
Jasmin Khateeb, Yuchong Li, Haibo Zhang · 2021 · Critical Care
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
Yuan, Shuofeng, Ye, Zi-Wei, Liang, Ronghui, Tang, Kaiming, Zhang, Anna Jinxia, Lu, Gang, Ong, Chon Phin, Man Poon, Vincent Kwok, Chan, Chris Chung-Sing, Mok, Bobo Wing-Yee et al. · 2022 · Science
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Chadi M. Saad-Roy, Sinead E. Morris, Charlotte Jessica E. Metcalf, Michael Joseph Mina, Rachel E. Baker, Jeremy Farrar, Edward Charles Holmes, Oliver G. Pybus, Andrea L. Graham, Simon A. Levin et al. · 2021 · Science
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
Giordano, Giulia, Colaneri, Marta, Di Filippo, Alessandro, Blanchini, Franco, Bolzern, Paolo, De Nicolao, Giuseppe, Sacchi, Paolo, Colaneri, Patrizio, Bruno, Raffaele · 2021 · Nature Medicine
Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness
Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Agha Mirza, Madison Conte, Nicholas Gallagher, Chun Huai Luo, Junko Jarrett, Ruifeng Zhou et al. · 2022 · Nature Microbiology
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA
Rebecca Earnest, Rockib Uddin, Nicholas N. Matluk, Nicholas Renzette, Sarah E. Turbett, Katherine J. Siddle, Christine Loreth, Gordon C. Adams, Christopher H. Tomkins-Tinch, Mary E. Petrone et al. · 2022 · Cell Reports Medicine
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Nicholas G. Davies, Christopher I Jarvis, CMMID COVID-19 Working Group, W. John Edmunds, Nicholas Patrick Jewell, Karla Diaz‐Ordaz, Ruth H. Keogh · 2021 · medRxiv
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, Vikram, Bhola, Shivam, Thakur, Pryanka, Patel, Sanjay Kumar Singh, Kulshrestha, Saurabh, Ratho, Radha Kanta, Kumar, Pradeep · 2022 · Infection
Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike
Bailey Lubinski, Maureen H.V. Fernandes, Laura E. Frazier, Tiffany Tang, Susan Daniel, Diego G. Diel, Javier A. Jaimes, Gary R. Whittaker · 2021 · iScience
A paper-based assay for the colorimetric detection of SARS-CoV-2 variants at single-nucleotide resolution
Ting Zhang, Ruijie Deng, Yuxi Wang, Chengyong Wu, Kaixiang Zhang, Chunyan Wang, Ningqiang Gong, Rodrigo Ledesma‐Amaro, Xucong Teng, Chunrong Yang et al. · 2022 · Nature Biomedical Engineering
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Greaney, Allison J., Loes, Andrea N., Crawford, Katharine H.D., Starr, Tyler N., Malone, Keara D., Chu, Helen Y., Bloom, Jesse D. · 2021
Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
Chee Wah Tan, Wanni Chia, Barnaby Edward Young, Feng Zhu, Beng Lee Lim, Wan Rong Sia, Tun-Linn Thein, Mark I-Cheng Chen, Yee‐Sin Leo, David Chien Lye et al. · 2021 · New England Journal of Medicine
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England
Bernal, Jamie Lopez, Andrews, Nick, Gower, Charlotte, Stowe, Julia, Robertson, Chris, Tessier, Elise, Simmons, Ruth, Cottrell, Simon, Roberts, Richard, O’Doherty, Mark et al. · 2021
Molecular basis of receptor binding and antibody neutralization of Omicron
Hong Qin, Wenyu Han, Jiawei Li, Shiqi Xu, Yifan Wang, Cong Xu, Zuyang Li, Yanxing Wang, Chao Zhang, Zhong Wei Huang et al. · 2022 · Nature
Viral variant-resolved wastewater surveillance of SARS-CoV-2 at national scale
Fabian Amman, Rudolf Markt, Lukas Endler, Sebastian Hupfauf, Benedikt Agerer, Anna Schedl, Lukas Richter, Melanie Zechmeister, Martin Bicher, Georg Heiler et al. · 2022 · Nature Biotechnology
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Mir Aroosa, Mrunal Shinde, Onur Bender, Farhan Alshammari, Mukhtar Ansari, Sirajudheen Anwar · 2022 · Journal of Infection and Public Health
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
Grint, Daniel J, Wing, Kevin, Williamson, Elizabeth, McDonald, Helen I, Bhaskaran, Krishnan, Evans, David, Evans, Stephen JW, Walker, Alex J, Hickman, George, Nightingale, Emily et al. · 2021 · Eurosurveillance
Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence
Moritz U. G. Kraemer, Verity Hill, Christopher Ruis, Simon Dellicour, Sumali Bajaj, John T. McCrone, Guy Baele, Kris V. Parag, Anya Lindström Battle, Bernardo Gutiérrez et al. · 2021 · Science
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, Adannaya Amadi, David C. Gaston, Maggie Li, Nicholas J. Swanson, Matthew C. Schwartz, Eili Y. Klein, Andrew S Pekosz et al. · 2021 · Clinical Infectious Diseases
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, Penny L. Moore, Thomas Friedrich Schulz, Alexander Muik, Uğur Şahin, Özlem Türeci, Shanti Pather · 2022 · mBio
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
Paul Elliott, David Haw, Haowei Wang, Oliver D. Eales, Caroline E. Walters, Kylie E. C. Ainslie, Christina Joanne Atchison, Claudio Fronterrè, Peter John Diggle, Andrew J. Page et al. · 2021 · Science
SARS-CoV-2 wastewater surveillance data can predict hospitalizations and ICU admissions
Aikaterini Galani, Reza Aalizadeh, Marios G. Kostakis, Athina N. Markou, ‪Nikiforos Alygizakis, Theodore Lytras, Panagiotis G. Adamopoulos, Jordan Peccia, David C. Thompson, Aikaterini Kontou et al. · 2021 · The Science of The Total Environment
Proteolytic activation of SARS‐CoV‐2 spike protein
Makoto Takeda · 2021 · Microbiology and Immunology
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Renuka Raman, Krishna J. Patel, Kishu Ranjan · 2021 · Biomolecules
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, Nell Saunders, Rémy Robinot, Ludivine Grzelak, Delphine Planas, Jérémy Dufloo, Stacy Gellenoncourt, Alice Bongers et al. · 2021 · The EMBO Journal
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Walls, Alexandra C., Miranda, Marcos C., Schäfer, Alexandra, Pham, Minh N., Greaney, Allison, Arunachalam, Prabhu S., Navarro, Mary-Jane, Tortorici, M. Alejandra, Rogers, Kenneth, O’Connor, Megan A. et al. · 2021 · Cell
Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George F. Gao, Wenjie Tan, Guizhen Wu, Miao Xu, Zhiyong Lou et al. · 2021 · The Lancet Infectious Diseases
Public health actions to control new SARS-CoV-2 variants
Grubaugh, Nathan D., Hodcroft, Emma B., Fauver, Joseph R., Phelan, Alexandra L., Cevik, Muge · 2021 · Cell
The Evolution and Biology of SARS-CoV-2 Variants
Amalio Telenti, Emma B. Hodcroft, David L. Robertson · 2022 · Cold Spring Harbor Perspectives in Medicine
Structural basis for SARS-CoV-2 Delta variant recognition of ACE2 receptor and broadly neutralizing antibodies
Yifan Wang, Caixuan Liu, Chao Zhang, Yanxing Wang, Hong Qin, Shiqi Xu, Zuyang Li, Yong Ping Yang, Zhong Wei Huang, Yao Cong · 2022 · Nature Communications
Molecular dynamic simulation reveals E484K mutation enhances spike RBD-ACE2 affinity and the combination of E484K, K417N and N501Y mutations (501Y.V2 variant) induces conformational change greater than N501Y mutant alone, potentially resulting in an escape mutant
Gard Nelson, Oleksandr V. Buzko, Patricia Spilman, Kayvan Niazi, Shahrooz Rabizadeh, Patrick Soon‐Shiong · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
Chris R. Triggle, Devendra Bansal, Hong Ding, Md. Mazharul Islam, Elmoubasher Farag, Hamad Abdel Hadi, Ali A. Sultan · 2021 · Frontiers in Immunology
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies
Xing Quan Zhu, Dhiraj Mannar, Shanti Swaroop Srivastava, Alison Berezuk, Jean‐Philippe Demers, James W. Saville, Karoline Leopold, Wei Li, Dimiter Stanchev Dimitrov, Katharine S. Tuttle et al. · 2021 · PLoS Biology
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Vanshylla, Kanika, Di Cristanziano, Veronica, Kleipass, Franziska, Dewald, Felix, Schommers, Philipp, Gieselmann, Lutz, Gruell, Henning, Schlotz, Maike, Ercanoglu, Meryem S., Stumpf, Ricarda et al. · 2021 · Cell Host & Microbe
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
Frank Sandmann, Nicholas G. M. Davies, Anna Vassall, W. John Edmunds, Mark Jit, Fiona Yueqian Sun, Christian Julián Villabona‐Arenas, Emily Nightingale, Alicia Showering, Gwenan M. Knight et al. · 2021 · The Lancet Infectious Diseases
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
Michael D. Parkins, Bonita E. Lee, Nicole Acosta, María A. Bautista, Casey R. J. Hubert, Steve E. Hrudey, Kevin Frankowski, Xiaoli Pang · 2023 · Clinical Microbiology Reviews
The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation
Maaran Michael Rajah, Annie Bernier, Julian Buchrieser, Olivier Schwartz · 2021 · Journal of Molecular Biology
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity
Junxian Ou, Zhonghua Zhou, Ruixue Dai, Jing Zhang, Shan Zhao, Xiaowei Wu, Wendong Lan, Yi Ren, Lilian Cui, Qiaoshuai Lan et al. · 2021 · Journal of Virology
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
Pengcheng Han, Chao Su, Yanfang Zhang, Chongzhi Bai, Anqi Zheng, Chengpeng Qiao, Qing Wang, Sheng Niu, Qian Chen, Yuqin Zhang et al. · 2021 · Nature Communications
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study
Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, Katy A. M. Gaythorpe, Bimandra A Djaafara, Wes Hinsley, Richard G. FitzJohn et al. · 2021 · The Lancet
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Alexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, Shang Yu Gong, Romain Gasser, Guillaume Beaudoin-Bussières, Nathalie Brassard, Annemarie Laumaea, Dani Vézina, Jérémie Prévost et al. · 2021 · Cell Host & Microbe
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Qian He, Qunying Mao, Chaoqiang An, Jialu Zhang, Fan Gao, Lianlian Bian, Changgui Li, Zhenglun Liang, Miao Xu, Junzhi Wang · 2021 · Emerging Microbes & Infections
Evaluation of COVID-19 vaccination strategies with a delayed second dose
Seyed M. Moghadas, THOMAS NOGUEIRA VILCHES, Kevin Zhang, Shokoofeh Nourbakhsh, Pratha Sah, Meagan C. Fitzpatrick, Alison P. Galvani · 2021 · PLoS Biology
Factors Associated With Household Transmission of SARS-CoV-2
Zachary J. Madewell, Yang Yang, Ira M. Longini, M. Elizabeth Halloran, Natalie E. Dean · 2021 · JAMA Network Open
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, Logan T. Neel, Tharanath Shankar, Shriya Patel, Payton Lowery, Forrest Smith, Muralikrishnan Dhanasekaran, Timothy Moore · 2021 · Vaccines
Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants
Frank P. Esper, Thamali M. Adhikari, Zheng Jin Tu, Yu‐Wei Cheng, Kim El-Haddad, Daniel H. Farkas, David S. Bosler, Daniel D. Rhoads, Gary W. Procop, Jennifer S. Ko et al. · 2022 · The Journal of Infectious Diseases
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, William Barclay · 2021 · Journal of General Virology
Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study
Amy Gimma, James D Munday, Kerry LM Wong, Pietro Coletti, Kevin van Zandvoort, Kiesha Prem, CMMID COVID-19 working group, Petra Klepac, Gideon James Rubin, Sebastian Funk et al. · 2022 · PLoS Medicine
Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines
Daniele Focosi, Fabrizio Maggi · 2021 · Reviews in Medical Virology
Rapid detection of SARS-CoV-2 RNA in saliva via Cas13
Sita S. Chandrasekaran, Shreeya Agrawal, Alison Fanton, Aditya R. Jangid, Bérénice Charrez, Arturo M. Escajeda, Sungmin Son, Roger McIntosh, Huyen Tran, Abdul Muyeed Bhuiya et al. · 2022 · Nature Biomedical Engineering
Equitable access to COVID-19 vaccines makes a life-saving difference to all countries
Yang Ye, Qingpeng Zhang, Xuan Wei, Zhidong Cao, Hsiang‐Yu Yuan, Daniel Dajun Zeng · 2022 · Nature Human Behaviour
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Verity Hill, Louis du Plessis, Thomas P. Peacock, Dinesh Aggarwal, Rachel Colquhoun, Alessandro M. Carabelli, Nicholas A.F. Ellaby, Eileen Gallagher, Natalie Groves, Ben Jackson et al. · 2022 · Virus Evolution
Controlling COVID-19 via test-trace-quarantine
Cliff C. Kerr, Dina Mistry, Robyn M. Stuart, Katherine Rosenfeld, Gregory R. Hart, Rafael C. Núñez, Jamie A. Cohen, Prashanth Selvaraj, Romesh Abeysuriya, Michał Jastrzębski et al. · 2021 · Nature Communications
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, Rangarirai Makuku, Ayesha Mushtaq, Amjad Khan, Mariya Ivanovska, Sara A. Makka, Fareeda Hashem, Leander Penaso Marquez et al. · 2021 · Journal of Medical Virology
Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
Antonio F. Hernández, Daniela Cornelia Călina, Konstantinos A. Poulas, Anca Oana Docea, Aristidis Michael Tsatsakis · 2021 · Toxicology Reports
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity by Viral Load, S Gene Variants and Demographic Factors, and the Utility of Lateral Flow Devices to Prevent Transmission
Lennard Y. W. Lee, Stefan Rozmanowski, Matthew Pang, André Charlett, Charlotte S Anderson, Gareth J Hughes, Matthew Barnard, Leon Peto, Richard Vipond, Alex Sienkiewicz et al. · 2021 · Clinical Infectious Diseases
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, Arinjay Banerjee, Karen Louise Mossman · 2021 · Virology Journal
Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, Jasper Fuk‐Woo Chan, Maple Wang, Liyuan Liu, Yang Luo, Hin Chu, Yiming Huang, Manoj S. Nair et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality
Felipe André Zeiser, Bruna Donida, Cristiano André da Costa, Gabriel de Oliveira Ramos, Juliana Nichterwitz Scherer, Nêmora Tregnago Barcellos, Ana Paula Alegretti, Maria Letícia Rodrigues Ikeda, Ana Paula Wernz C. Müller, Henrique C. Bohn et al. · 2021 · The Lancet Regional Health - Americas
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, Morten Rasmussen, Mads Albertsen, Thomas Yssing Michaelsen, Camilla Holten Møller, Steen Ethelberg, Rebecca A. Legarth, Mia Sarah Fischer Button et al. · 2021 · The Lancet Infectious Diseases
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment
Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Barton F. Haynes · 2021 · Annual Review of Medicine
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
Matthias Becker, Alex Dulovic, Daniel Junker, Natalia Ruétalo, Philipp D. Kaiser, Yudi Tatiana Pinilla, Constanze Heinzel, Julia Häring, Bjoern Traenkle, Teresa R. Wagner et al. · 2021 · Nature Communications
Characterization of the Second Wave of COVID-19 in India
Rajesh Ranjan, Aryan Sharma, Mahendra Kumar Verma · 2021 · Current Science
Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication
Junjun Chu, Changsheng Xing, Yang Du, Tianhao Duan, Siyao Liu, Pengfei Zhang, Chumeng Cheng, Jill E. Henley, Xin Liu, Qian Chen et al. · 2021 · Nature Metabolism
Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021
Min Kang, Hualei Xin, Jun Yuan, Sheikh Taslim Ali, Zimian Liang, Jiayi Zhang, Ting Hu, Eric H. Y. Lau, Yingtao Zhang, Meng Zhang et al. · 2022 · Eurosurveillance
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
McCallum, Matthew, Marco, Anna De, Lempp, Florian, Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex, Liu, Zhuoming, Zatta, Fabrizia et al. · 2021
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England
Edward Knock, Lilith K. Whittles, John A. Lees, Pablo N. Perez‐Guzman, Robert Verity, Richard G. FitzJohn, Katy A. M. Gaythorpe, Natsuko Imai, Wes R. Hinsley, Lucy Okell et al. · 2021 · Science Translational Medicine
Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains
Simón A. Rella, Yuliya A. Kulikova, Emmanouil T. Dermitzakis, Fyodor A. Kondrashov · 2021 · Scientific Reports
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, Jurandy Júnior Ferraz de Magalhães, Justin R. J. Vigar, Abelardo Silva‐Júnior, Alain Kohl et al. · 2022 · ACS Infectious Diseases
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
Weilin Zhou, Wei Wang · 2021 · Signal Transduction and Targeted Therapy
Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil
Severino Jefferson Ribeiro da Silva, Lindomar Pena · 2021 · One Health
Controlling the pandemic during the SARS-CoV-2 vaccination rollout
João Viana, Christiaan Hendrik van Dorp, Ana Nunes, Manuel C. Gomes, Michiel van Boven, Mirjam Kretzschmar, Marc Veldhoen, Ganna Rozhnova · 2021 · Nature Communications
Defining Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placentitis
Jaclyn C. Watkins, Vanda F. Torous, Drucilla Jane Roberts · 2021 · Archives of Pathology & Laboratory Medicine
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies
Xun Wang, Xiaoyu Zhao, Jieyu Song, Jing Wu, Yuqi Zhu, Minghui Li, Yuchen Cui, Yanjia Chen, Lulu Yang, Jun Liu et al. · 2022 · Emerging Microbes & Infections
mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants
Aurélien Sokal, Giovanna Barba Spaeth, Ignacio Fernández, Matteo Broketa, Imane Azzaoui, Andréa de La Selle, Alexis Vandenberghe, Slim Fourati, Anaïs Roeser, Annalisa Meola et al. · 2021 · Immunity
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis
Tommy Nyberg, Katherine A. Twohig, Ross Harris, Shaun R. Seaman, Joe Flannagan, Hester Allen, André Charlett, Daniela De Angelis, Gavin Dabrera, Anne Margaret Presanis · 2021 · Apollo (University of Cambridge)
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
Katherine Laiton‐Donato, Carlos Franco-Muñoz, Diego Alejandro Álvarez-Díaz, Héctor Alejandro Ruiz-Moreno, José Aldemar Usme-Ciro, Diego Prada-Cardozo, Jhonnatan Reales-González, Sheryll Corchuelo, María T. Herrera-Sepúlveda, Julián Naizaque et al. · 2021 · Infection Genetics and Evolution
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
Yang, Ren, Deng, Yao, Huang, Baoying, Huang, Lei, Lin, Ang, Li, Yuhua, Wang, Wenling, Liu, Jingjing, Lu, Shuaiyao, Zhan, Zhenzhen et al. · 2021 · Signal Transduction and Targeted Therapy
New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge
Salsabil Islam, Towhidul Islam, Md. Rabiul Islam · 2022 · Clinical Pathology
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Renato Mendes Coutinho, Flávia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes, Otavio Canton, Tatiana Pineda Portella, Silas Poloni, Caroline Fernandes Jaegger Franco, Mateusz M. Pluciński et al. · 2021 · Communications Medicine
Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
Martina Patone, Karen Thomas, Robert Alan Hatch, Pui San Tan, Carol A. C. Coupland, Weiqi Liao, Paul Mouncey, David A Harrison, Kathy Rowan, Peter Horby et al. · 2021 · The Lancet Infectious Diseases
Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people
Joshua Elliott, Matthew D. Whitaker, Barbara Bodinier, Oliver D. Eales, Steven Riley, Helen Ward, Graham Cooke, Ara Wardkes Darzi, Marc Chadeau‐Hyam, Paul Elliott · 2021 · PLoS Medicine
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
Matthew McCallum, Jessica Bassi, Anna De Marco, Alex Chen, Alexandra C. Walls, Julia di Iulio, M. Alejandra Tortorici, Mary-Jane Navarro, Chiara Silacci-Fregni, Christian Saliba et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
Tara Alpert, Anderson Fernandes Brito, Erica Lasek‐Nesselquist, Jessica E. Rothman, Andrew L. Valesano, Matthew J. MacKay, Mary E. Petrone, Mallery I. Breban, Anne E. Watkins, Chantal B. F. Vogels et al. · 2021 · Cell
Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants
Anshumali Mittal, Arun Khattri, Vikash Verma · 2022 · PLoS Pathogens
Next-Generation Sequencing (NGS) in COVID-19: A Tool for SARS-CoV-2 Diagnosis, Monitoring New Strains and Phylodynamic Modeling in Molecular Epidemiology
Goldin John, Nikhil Sahajpal, Ashis Kumar Mondal, Sudha Ananth, Colin Williams, Alka Chaubey, Amyn M. Rojiani, Ravindra B Kolhe · 2021 · Current Issues in Molecular Biology
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, Anouschka Akerman, Camille Esneau, Vanessa Milogiannakis, Deborah Lilly Burnett, Samantha McAllery, Mariana Ruiz Silva, Yonghui Lu et al. · 2022 · Nature Microbiology
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Angel Yun-Kuan Thye, Jodi Woan‐Fei Law, Priyia Pusparajah, Vengadesh Letchumanan, Kok‐Gan Chan, Learn−Han Lee · 2021 · Biomedicines
Adaptation, spread and transmission of SARS-CoV-2 in farmed minks and associated humans in the Netherlands
Lu Lu, Reina S. Sikkema, Francisca C. Velkers, David F. Nieuwenhuijse, Egil A.J. Fischer, Paola A. Meijer, Noortje Bouwmeester-Vincken, Ariene Rietveld, Marjolijn C. A. Wegdam-Blans, Paulien Tolsma et al. · 2021 · Nature Communications
Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
Robert M. Cox, Josef D. Wolf, Carolin M. Lieber, Julien Sourimant, Michelle J. Lin, Darius M. Babusis, Venice Du Pont, Julie Chan, Kim Barrett, Diane S. Lye et al. · 2021 · Nature Communications
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, S. Gobeil, Dapeng Li, Gabriela De la Cruz, Robert Parks, Xiaozhi Lu, Maggie Barr, Victoria Stalls, Katarzyna Janowska et al. · 2021 · Science Translational Medicine
S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021
Kevin Antoine Brown, Jonathan B. Gubbay, Jessica P. Hopkins, Samir N. Patel, Sarah A. Buchan, Nick Daneman, Lee William Goneau · 2021 · JAMA
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
Sun, Shihui, Gu, Hongjing, Cao, Lei, Chen, Qi, Ye, Qing, Yang, Guan, Li, Rui-Ting, Fan, Hang, Deng, Yong-Qiang, Song, Xiaopeng et al. · 2021 · Nature Communications
Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
Rana Abdelnabi, Robbert Boudewijns, Caroline Shi-Yan Foo, Laura Seldeslachts, Lorena Sánchez-Felipe, Xin Zhang, Leen Delang, Piet Maes, Suzanne J. F. Kaptein, Birgit Weynand et al. · 2021 · EBioMedicine
Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021
Juan Yang, Valentina Marziano, Xiaowei Deng, Giorgio Guzzetta, Juanjuan Zhang, Filippo Trentini, Jun Cai, Piero Poletti, Wen Zheng, Wei Wang et al. · 2021 · Nature Human Behaviour
The Spike of Concern—The Novel Variants of SARS-CoV-2
Anna Winger, Thomas Caspari · 2021 · Viruses
Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis
Chen, Xinhua, Chen, Zhiyuan, Azman, Andrew S, Sun, Ruijia, Lu, Wanying, Zheng, Nan, Zhou, Jiaxin, Wu, Qianhui, Deng, Xiaowei, Zhao, Zeyao et al. · 2022 · Clinical Infectious Diseases
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Tada, Takuya, Dcosta, Belinda M., Samanovic-Golden, Marie, Herati, Ramin S., Cornelius, Amber, Mulligan, Mark J., Landau, Nathaniel R. · 2021